ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 261726 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 261726; 2) Community: the network communities that were significantly associated with the response to NSC 261726; 3) Molecule: the relationships between components within communities and NSC 261726; 4) MDR: the compounds that were significantly associated with the NSC 261726.

NSC Compound Enrichment Correlation
NSC 163062 TRIPTOLIDE 0.0133986477026052 0.28535095
NSC 349622 Cytovaricin 0.0137891122538509 0.14175749
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0137891122538509 0.23995019
NSC 606497 Camptothecin Derivative 0.0137891122538509 0.25948904
NSC 63878 Cytarabine Hydrochloride AZ 0.0137891122538509 0.30305945
NSC 643838 Null 0.0137891122538509 -0.039344357
NSC 644622 Null 0.0137891122538509 0.25178524
NSC 645665 Null 0.0137891122538509 0.1780262
NSC 646140 Null 0.0137891122538509 0.089922597
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0137891122538509 0.27446879
Total:73  Current:27    [First] [Prev] [Next] [Last]